Center Leadership

Holly Tabor, PhD, is the Director of the Stanford Center for Biomedical Ethics. She is Professor of Medicine at Stanford University, and by Courtesy of Pediatrics and Epidemiology and Population Health. She is also Co-Chair of the Ethics Committees at Stanford Hospital and Lucile Packard Children's Hospital. She is a globally recognized expert on the ethical issues surrounding health care and research for patients with disabilities, especially intellectual and developmental disability, and on the ethical, legal, and social issues (ELSI) in genetics. Her research has shed light on the benefits and risks of participating in genomic research, particularly of rare and undiagnosed diseases. She is Editor-in-Chief of the American Journal of Bioethical Empirical Research. 

Mildred Cho, PhD, Associate Director of Research at the Center is also Professor of Pediatrics. Her major areas of interest are the ethical and social issues raised by new technologies such as genetic testing, gene therapy, and artificial intelligence. She also studies how biomedical researchers can be encouraged to integrate ethical issues into their work.

Henry Greely, JD, Chair of SCBE's Steering Committee, is Professor of Law and Professor, by courtesy, of Genetics at Stanford University. Specializing in health law and policy, Greely has written on cloning, the implications of genetics for the health care system, health care insurance and financing and the stem cell debate.

David MagnusPhD,  is Thomas A. Raffin Professor of Medicine and Biomedical Ethics, and Professor of Pediatrics, Medicine, and by Courtesy of Bioengineering and Associate Dean of Research at Stanford University. He is a member of the Stanford Hospital and Clinics Ethics Committee, is past President of the Association of Bioethics Program Directors, and is the Editor-in-Chief of the American Journal of Bioethics. He is currently the Vice-Chair of the IRB for the NIH Precision Medicine Initiative (“All of Us”).

Thomas A. Raffin, MD, Co-Founder and Director Emeritus of the Center, is Colleen and Robert Haas Professor Emeritus of Medicine and Bioethics and former Chief of the Division of Pulmonary and Critical Care Medicine. In addition to biomedical ethics (withholding and withdrawing life support, medical decision-making in the context of managed care and HMOs, ethics of neurosciences, and ethical issues in human genetics), Dr. Raffin's other key areas of academic interest include the biology of acute lung injury, pulmonary fibrosis, and lymphangioleiomyomatosis.